Assenagon Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.6M Buy
864,395
+344,221
+66% +$16.3M 0.05% 282
2026
Q1
$26.8M Buy
520,174
+255,175
+96% +$17.9M 0.04% 291
2025
Q4
$24.4M Buy
+264,999
New +$25.4M 0.03% 333
2024
Q4
Sell
-1,541
Closed -$325K 1390
2024
Q3
$325K Hold
1,541
﹤0.01% 1291
2024
Q2
$206K Sell
1,541
-1,796
-54% -$340K ﹤0.01% 1370
2024
Q1
$717K Sell
3,337
-9,812
-75% -$1.92M ﹤0.01% 1125
2023
Q4
$2.67M Sell
13,149
-23,820
-64% -$3.86M 0.01% 828
2023
Q3
$7.34M Sell
36,969
-55,377
-60% -$14M 0.02% 466
2023
Q2
$30M Buy
92,346
+51,280
+125% +$14.7M 0.1% 158
2023
Q1
$9.61M Sell
41,066
-298,563
-88% -$75.5M 0.03% 395
2022
Q4
$85.5M Buy
+339,629
New +$72.4M 0.31% 72
2022
Q2
Sell
-1,052
Closed -$270K 1520
2022
Q1
$270K Hold
1,052
﹤0.01% 1312
2021
Q4
$242K Sell
1,052
-55,000
-98% -$13.4M ﹤0.01% 1335
2021
Q3
$13.1M Buy
56,052
+35,014
+166% +$7.31M 0.04% 257
2021
Q2
$4.07M Buy
+21,038
New +$4.17M 0.01% 530
2020
Q3
Sell
-39,856
Closed -$3.47M 1233
2020
Q2
$3.47M Buy
39,856
+30,983
+349% +$2.38M 0.02% 426
2020
Q1
$535K Buy
+8,873
New +$657K ﹤0.01% 630
2019
Q3
Sell
-18,206
Closed -$1.1M 945
2019
Q2
$1.1M Buy
+18,206
New +$981K 0.01% 692

Other funds holding INSP

Assenagon Asset Management's INSP Position: Q2 2026 in Review

Assenagon Asset Management increased its Inspire Medical Systems (INSP) stake by 66% in Q2 2026, buying an estimated $16.3M and bringing the position to 864,395 shares worth $38.6M. The position accounts for 0.05% of the portfolio, ranked #282.

Assenagon Asset Management first reported a position in INSP in Q2 2019 and has held it in 18 quarters since. The position peaked at $85.5M in Q4 2022. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Assenagon Asset Management held 864,395 shares of Inspire Medical Systems worth $38.6M as of Q2 2026.
  • Assenagon Asset Management bought 344,221 Inspire Medical Systems shares in Q2 2026, an estimated $16.3M.
  • Inspire Medical Systems made up 0.05% of Assenagon Asset Management's portfolio in Q2 2026, its #282 holding.
  • Assenagon Asset Management first reported a position in Inspire Medical Systems in Q2 2019 and has held it in 18 quarters since.
  • Assenagon Asset Management's Inspire Medical Systems position peaked at $85.5M in Q4 2022.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.